American Heart Association Praises Selection of Gibbons as New NHLBI Director

April 05, 2012 Categories: Advisories & Comments, Advocacy News
Washington, D.C., April 5, 2012 American Heart Association CEO Nancy Brown issued the following statement today on the National Institutes of  Health’s selection of Gary H. Gibbons, M.D., as the new director of the NIH’s National Heart, Lung, and Blood Institute:
 
“The American Heart Association congratulates Dr. Gary Gibbons on his appointment as director of the National Heart, Lung, and Blood Institute (NHLBI). We commend NIH Director Francis Collins on his choice of Dr. Gibbons, who has been a committed volunteer and longtime friend to the association.
 
Dr. Gibbons has helped to advance the American Heart Association’s mission in many wonderful ways.  He is a fellow of the association and a current member of our Council on High Blood Pressure Research. Dr. Gibbons has served on the editorial boards of the association’s medical journals Circulation, Circulation Research and Hypertension. In 1998, he received an American Heart Association Established Investigator Award. He is a past member of numerous panels, including our Publishing Committee and Committee on Scientific Sessions Program, and is very involved in association initiatives in Atlanta and with our Greater Southeast Affiliate.
 
Dr. Gibbons also brings along broad research and clinical experience, and a thorough understanding of the NIH’s grant process. As founder and director of the Morehouse School of Medicine’s Cardiovascular Research Institute, Dr. Gibbons gained national recognition as a clinician-scientist directing research in vascular biology, genomic medicine and the pathogenesis of vascular disease. His institute at Morehouse, an NIH-funded Research Center of Excellence, is preeminent in discovery science related to the cardiovascular health of minority populations.
 
NHLBI has and will continue to play a critical role in helping the American Heart Association achieve its 2020 goal to improve the cardiovascular health of all Americans by 20 percent, and to reduce deaths from cardiovascular diseases and stroke by 20 percent. Dr. Gibbon’s rich experience and longtime dedication to cardiovascular health will make him an excellent partner in the fight against heart disease and stroke. We look forward to working with him.”
 
###
Contact:  Retha Sherrod, (202) 785-7929; retha.sherrod@heart.org